EBAC

European Biotech Acquisition Corp. Class A Ordinary Shares

Delisted

EBAC was delisted on the 2nd of March, 2023.

45 hedge funds and large institutions have $69.6M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+4
Holders Change %
+9.76%
% of All Funds
0.69%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
4
Reduced
1
Closed
2
Calls
$8K
Puts
Net Calls
+$8K
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
GF
26
Gabelli Funds
New York
$710K
GCIA
27
Gabelli & Co Investment Advisers
New York
$637K
WA
28
Whitebox Advisors
Minnesota
$528K
SCC
29
Spring Creek Capital
Kansas
$485K
EAM
30
Exos Asset Management
New York
$439K
ACM
31
Atalaya Capital Management
New York
$388K
MP
32
Mangrove Partners
Connecticut
$383K
VI
33
Vestcor Inc
New Brunswick, Canada
$340K
OAC
34
OMERS Administration Corp
Ontario, Canada
$339K
KCM
35
Kawa Capital Management
Florida
$262K +$262K +27,000 New
WRBC
36
W.R. Berkley Corp
Connecticut
$190K
DIG
37
DeepCurrents Investment Group
New York
$172K +$172K +17,730 New
LCM
38
Landscape Capital Management
New Jersey
$106K
MF
39
Magnetar Financial
Illinois
$100K
PCM
40
Prelude Capital Management
New York
$97K
AA
41
Ancora Advisors
Ohio
$68K
PCM
42
Pinz Capital Management
New York
$23K +$23K +2,331 New
GCL
43
Glazer Capital LLC
New York
$19K
DFCM
44
Dark Forest Capital Management
Puerto Rico
$15K +$15K +1,579 New
UBS Group
45
UBS Group
Switzerland
$2K
AC
46
Athanor Capital
New York
-$1.43M -147,800 Closed
WAM
47
Wolverine Asset Management
Illinois
-$4K -499 Closed